Compare USIO & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | USIO | INCR |
|---|---|---|
| Founded | 1998 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.8M | 47.4M |
| IPO Year | 1999 | 2021 |
| Metric | USIO | INCR |
|---|---|---|
| Price | $1.96 | $0.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 160.8K | 18.4K |
| Earning Date | 05-13-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | N/A |
| Revenue | ★ $28,200,535.00 | N/A |
| Revenue This Year | $12.15 | $69.54 |
| Revenue Next Year | $8.57 | $41.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.69 | N/A |
| 52 Week Low | $1.03 | $0.68 |
| 52 Week High | $2.62 | $1.77 |
| Indicator | USIO | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 45.67 | 44.79 |
| Support Level | $1.36 | $0.85 |
| Resistance Level | $2.61 | $0.98 |
| Average True Range (ATR) | 0.18 | 0.05 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 14.86 | 37.47 |
Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.